BACKGROUND: Three tools are currently available to predict the risk of contralateral breast cancer (CBC). We aimed to compare the performance of the Manchester formula, CBCrisk, and PredictCBC in patients with invasive breast cancer (BC). METHODS: We analyzed data of 132,756 patients (4682 CBC) from 20 international studies with a median follow-up of 8.8 years. Prediction performance included discrimination, quantified as a time-dependent Area-Under-the-Curve (AUC) at 5 and 10 years after diagnosis of primary BC, and calibration, quantified as the expected-observed (E/O) ratio at 5 and 10 years and the calibration slope. RESULTS: The AUC at 10 years was: 0.58 (95% confidence intervals [CI] 0.57-0.59) for CBCrisk; 0.60 (95% CI 0.59-0.61) for...
AIM: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral br...
BACKGROUND: Mammographic density (MD) is an established predictor of risk of a first breast cancer, ...
Breast cancer is the most common cancer diagnosis and second leading cause of death in women. Risk f...
Background: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND:Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the conse...
BACKGROUND: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
Correction: Volume 24, Issue 1 Article Number 82 DOI: 10.1186/s13058-022-01579-zBackground: Predicti...
Background: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
Women with breast cancer often wonder whether they should have their other breast removed as well, t...
Population-based estimates are lacking for the temporal trends in the contralateral breast cancer (C...
Background Three tools are currently available to predict the risk of contralateral breast cancer (C...
We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ ...
Due to the increased incidence of breast cancer and improved survival, more women are at risk of dev...
BACKGROUND: Although 2-20% of breast cancer patients develop a contralateral breast cancer (CBC), pr...
AIM: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral br...
BACKGROUND: Mammographic density (MD) is an established predictor of risk of a first breast cancer, ...
Breast cancer is the most common cancer diagnosis and second leading cause of death in women. Risk f...
Background: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
BACKGROUND: Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the cons...
BACKGROUND:Breast cancer survivors are at risk for contralateral breast cancer (CBC), with the conse...
BACKGROUND: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
Correction: Volume 24, Issue 1 Article Number 82 DOI: 10.1186/s13058-022-01579-zBackground: Predicti...
Background: Prediction of contralateral breast cancer (CBC) risk is challenging due to moderate perf...
Women with breast cancer often wonder whether they should have their other breast removed as well, t...
Population-based estimates are lacking for the temporal trends in the contralateral breast cancer (C...
Background Three tools are currently available to predict the risk of contralateral breast cancer (C...
We aimed to assess contralateral breast cancer (CBC) risk in patients with ductal carcinoma in situ ...
Due to the increased incidence of breast cancer and improved survival, more women are at risk of dev...
BACKGROUND: Although 2-20% of breast cancer patients develop a contralateral breast cancer (CBC), pr...
AIM: BRCA1/2 mutation carriers with primary breast cancer (PBC) are at high risk of contralateral br...
BACKGROUND: Mammographic density (MD) is an established predictor of risk of a first breast cancer, ...
Breast cancer is the most common cancer diagnosis and second leading cause of death in women. Risk f...